Table 3.
Comparison between groups depending on decline in eGFR. The statistically significant parameters are bolded in the table.
| Parameter | eGFR Reduction > 50% | p-Value | |
|---|---|---|---|
| No (N = 73) | Yes (N = 7) | ||
| Age (years) | 39 ± 13 | 44 ± 19 | 0.36 |
| SBP (mmHg) | 131 ± 16 | 133 ± 16 | 0.79 |
| DBP (mmHg) | 80 ± 11 | 79 ± 0 | 0.7 |
| MAP (mmHg) | 96 ± 12 | 95 ± 10 | 0.89 |
| NLR | 2.4 ± 1.5 | 3.0 ± 1.9 | 0.27 |
| PLR | 135 ± 54 | 189 ± 86 | 0.02 |
| Total cholesterol (mg/dL) | 256 ± 104 | 281 ± 105 | 0.55 |
| Triglycerides (mg/dL) | 171 ± 92 | 183 ± 95 | 0.74 |
| Uric acid (mg/dL) | 6.5 ± 1.8 | 7.0 ± 1.0 | 0.45 |
| Fasting glucose (mg/dL) | 93 ± 11 | 93 ± 12 | 0.93 |
| Serum albumin (g/dL) | 3.6 ± 0.9 | 2.6 ± 0.6 | 0.002 |
| Total protein (g/dL) | 6.2 ± 1.2 | 4.8 ± 1.9 | 0.004 |
| Serum creatinine (mg/dL) | 1.4 ± 1.1 | 1.1 ± 0.3 | 0.6 |
| eGFR (mL/min/1.73 m2) | 67 ± 24 | 81 ± 26 | 0.16 |
| UPCR (g/g) | 1.7 ± 2.1 | 3.6 ± 2.5 | 0.02 |
| Erythrocyturia—moderate | 29 (40%) | 4 (57%) | 0.62 |
| Erythrocyturia—severe | 27 (37%) | 1 (14%) | 0.49 |
| Hypertension | 33 (45%) | 6 (86%) | 0.1 |
| ACEI treatment | 47 (64%) | 5 (71%) | 0.97 |
| Prednisone use at the time of biopsy | 13 (18%) | 5 (71%) | 0.006 |
| Prednisone use after biopsy | 32 (44%) | 6 (86%) | 0.08 |